The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic significance of human epidermal growth factor-2 (HER2) in advanced gastric cancer: A U.S. and European international collaborative analysis.
M. A. Shah
Research Funding - Genentech
Y. Y. Janjigian
Consultant or Advisory Role - Genentech
C. Pauligk
No relevant relationships to disclose
D. Werner
No relevant relationships to disclose
D. P. Kelsen
No relevant relationships to disclose
E. Jaeger
No relevant relationships to disclose
H. Altmannsberger
No relevant relationships to disclose
E. Robinson
No relevant relationships to disclose
L. H. Tang
No relevant relationships to disclose
V. V. Barbashina
No relevant relationships to disclose
S. Al-Batran
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche